Marcellin, P. Et Al. 2013. Seven Years of Treatment with Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated with Sustained Virological, Biochemical and Serological Responses with no Detectable Resistance. 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , (Washington, Kiribati).

Marcellin, P., Gane, E. J., Tsai, N., Flisiak, R., Petersen, J., GÜREL, S., ... Kotzev, I. A.(2013). Seven Years of Treatment with Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated with Sustained Virological, Biochemical and Serological Responses with no Detectable Resistance . 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati

Marcellin, Patrick Et Al. "Seven Years of Treatment with Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated with Sustained Virological, Biochemical and Serological Responses with no Detectable Resistance," 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 2013

Marcellin, Patrick Et Al. "Seven Years of Treatment with Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated with Sustained Virological, Biochemical and Serological Responses with no Detectable Resistance." 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , Washington, Kiribati, 2013

Marcellin, P. Et Al. (2013) . "Seven Years of Treatment with Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated with Sustained Virological, Biochemical and Serological Responses with no Detectable Resistance." 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , Washington, Kiribati.

@conferencepaper{conferencepaper, author={Patrick Marcellin Et Al. }, title={Seven Years of Treatment with Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated with Sustained Virological, Biochemical and Serological Responses with no Detectable Resistance}, congress name={64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases}, city={Washington}, country={Kiribati}, year={2013}}